• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis.甲状腺乳头状癌转移前引流淋巴结的结构改变
Head Neck. 2017 Aug;39(8):1639-1646. doi: 10.1002/hed.24807. Epub 2017 May 3.
2
Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.术前细针穿刺活检 BRAF 分析预测甲状腺乳头状癌隐匿性中央淋巴结转移:一项前瞻性研究。
J Clin Endocrinol Metab. 2012 Nov;97(11):3996-4003. doi: 10.1210/jc.2012-2444. Epub 2012 Aug 28.
3
BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.BRAF V600E 突变可独立预测甲状腺乳头状癌患者中央区淋巴结转移。
Ann Surg Oncol. 2013 Jan;20(1):47-52. doi: 10.1245/s10434-012-2611-0. Epub 2012 Sep 1.
4
BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.甲状腺微小乳头状癌及其配对淋巴结转移灶中的BRAF V600E突变与p27 kip1表达
Cancer. 2007 Sep 15;110(6):1218-26. doi: 10.1002/cncr.22912.
5
Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.淋巴绘图确定了BRAF基因突变在甲状腺乳头状癌中的作用。
Ann Surg. 2006 Nov;244(5):799-804. doi: 10.1097/01.sla.0000224751.80858.13.
6
High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.BRAF突变在转移性甲状腺乳头状癌淋巴结中的高发生率及可能的新发形成。
J Clin Endocrinol Metab. 2005 Sep;90(9):5265-9. doi: 10.1210/jc.2004-2353. Epub 2005 Jul 5.
7
Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.甲状腺微小乳头状癌手术的临床病理特征、预后及其与BRAFV600E突变状态和血管生成因子表达的关系
PLoS One. 2016 Dec 9;11(12):e0167414. doi: 10.1371/journal.pone.0167414. eCollection 2016.
8
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.甲状腺乳头状癌滤泡变体中罕见的BRAF突变:新见解
Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.
9
MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse.甲状腺乳头状癌中MUC1的表达与BRAF突变及淋巴结转移相关;后者是复发的最重要危险因素。
Thyroid. 2014 Sep;24(9):1375-84. doi: 10.1089/thy.2013.0594. Epub 2014 Aug 1.
10
Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.BRAF(V600E)突变与大量传统型乳头状甲状腺癌患者超声特征及临床病理特征的相关性
PLoS One. 2014 Oct 22;9(10):e110868. doi: 10.1371/journal.pone.0110868. eCollection 2014.

引用本文的文献

1
Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy.肿瘤引流淋巴结在联合免疫治疗和放疗的远隔效应中的关键作用。
Cancer Commun (Lond). 2022 Oct;42(10):971-986. doi: 10.1002/cac2.12348. Epub 2022 Aug 13.
2
LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.含LEM结构域蛋白1通过激活Wnt/β-连环蛋白信号通路和上皮-间质转化促进甲状腺癌细胞增殖和迁移。
Oncol Lett. 2021 Jun;21(6):442. doi: 10.3892/ol.2021.12703. Epub 2021 Apr 2.
3
Lymph Node Subcapsular Sinus Microenvironment-On-A-Chip Modeling Shear Flow Relevant to Lymphatic Metastasis and Immune Cell Homing.淋巴结被膜下窦微环境芯片模型:模拟与淋巴转移和免疫细胞归巢相关的剪切流
iScience. 2020 Oct 31;23(11):101751. doi: 10.1016/j.isci.2020.101751. eCollection 2020 Nov 20.
4
Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.生长相关蛋白 43 通过上皮-间充质转化促进甲状腺癌细胞系的进展。
J Cell Mol Med. 2019 Dec;23(12):7974-7984. doi: 10.1111/jcmm.14460. Epub 2019 Sep 30.
5
NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.NECTIN4通过激活AKT促进甲状腺乳头状癌细胞的增殖、迁移和侵袭,并引发上皮-间质转化。
Cancer Manag Res. 2019 Apr 2;11:2565-2578. doi: 10.2147/CMAR.S190332. eCollection 2019.
6
Lipase member H is a downstream molecular target of hypoxia inducible factor-1α and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines.脂肪酶成员H是缺氧诱导因子-1α的下游分子靶点,并促进BCPAP和KTC-1细胞系中甲状腺乳头状癌细胞的迁移。
Cancer Manag Res. 2019 Jan 22;11:931-941. doi: 10.2147/CMAR.S183355. eCollection 2019.
7
CLDN10 is Associated with Papillary Thyroid Cancer Progression.紧密连接蛋白10与甲状腺乳头状癌进展相关。
J Cancer. 2018 Nov 25;9(24):4712-4717. doi: 10.7150/jca.28636. eCollection 2018.

本文引用的文献

1
Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss.肿瘤微环境中由成纤维细胞介导的胶原蛋白重塑促进了由BrafV600E和Pten缺失驱动的甲状腺癌进展。
Cancer Res. 2016 Apr 1;76(7):1804-13. doi: 10.1158/0008-5472.CAN-15-2351. Epub 2016 Jan 27.
2
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.淋巴管生成标志物及其对非小细胞肺癌淋巴结转移和生存的影响——一项荟萃分析的结构化综述
PLoS One. 2015 Aug 25;10(8):e0132481. doi: 10.1371/journal.pone.0132481. eCollection 2015.
3
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.伴淋巴结转移的甲状腺乳头状癌术后复发
J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.
4
Mouse models of thyroid cancer: A 2015 update.甲状腺癌小鼠模型:2015年更新
Mol Cell Endocrinol. 2016 Feb 5;421:18-27. doi: 10.1016/j.mce.2015.06.029. Epub 2015 Jun 27.
5
Host response. Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection.宿主反应。炎症引起的 SCS 巨噬细胞破坏,会损害 B 细胞对二次感染的反应。
Science. 2015 Feb 6;347(6222):667-72. doi: 10.1126/science.aaa1300.
6
Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis.激活BRAF和PIK3CA突变协同促进间变性甲状腺癌发生。
Mol Cancer Res. 2014 Jul;12(7):979-86. doi: 10.1158/1541-7786.MCR-14-0158-T. Epub 2014 Apr 25.
7
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.p53 限制了 BRAF 突变型甲状腺乳头状癌小鼠模型向间变性甲状腺癌的进展。
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1600-9. doi: 10.1073/pnas.1404357111. Epub 2014 Apr 7.
8
The role of the inflammatory microenvironment in thyroid carcinogenesis.炎症微环境在甲状腺癌发生中的作用。
Endocr Relat Cancer. 2014 Apr 28;21(3):R85-R103. doi: 10.1530/ERC-13-0431. Print 2014 Jun.
9
The next generation of orthotopic thyroid cancer models: immunocompetent orthotopic mouse models of BRAF V600E-positive papillary and anaplastic thyroid carcinoma.下一代原位甲状腺癌模型:BRAF V600E 阳性乳头状和间变性甲状腺癌的免疫活性原位小鼠模型。
Thyroid. 2014 Apr;24(4):705-14. doi: 10.1089/thy.2013.0483. Epub 2014 Jan 24.
10
Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.肿瘤细胞进入淋巴结受到淋巴结淋巴管中表达的趋化因子 CCL1 的控制。
J Exp Med. 2013 Jul 29;210(8):1509-28. doi: 10.1084/jem.20111627. Epub 2013 Jul 22.

甲状腺乳头状癌转移前引流淋巴结的结构改变

Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis.

作者信息

Hinson Andrew M, Massoll Nicole A, Jolly Lee Ann, Stack Brendan C, Bodenner Donald L, Franco Aime T

机构信息

Department of Otolaryngology - Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

出版信息

Head Neck. 2017 Aug;39(8):1639-1646. doi: 10.1002/hed.24807. Epub 2017 May 3.

DOI:10.1002/hed.24807
PMID:28467685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5695216/
Abstract

BACKGROUND

The purpose of this study was to define and characterize the thyroid tumor-draining lymph nodes in genetically engineered mice harboring thyroid-specific expression of oncogenic Braf with and without Pten insufficiency.

METHODS

After intratumoral injection of methylene blue, the lymphatic drainage of the thyroid gland was visualized in real time. The thyroid gland/tumor was resected en bloc with the respiratory system for histological analysis.

RESULTS

Although mice harboring Braf mutations were smaller in body size compared with their wild-type (WT) littermates, the size of their thyroid glands and deep cervical lymph nodes were significantly larger. Additionally, the tumor-draining lymph nodes showed increased and enlarged lymphatic sinuses that were distributed throughout the cortex and medulla. Tumor-reactive lymphadenopathy and histiocytosis, but no frank metastases, were observed in all mice harboring Braf mutations.

CONCLUSIONS

The tumor-draining lymph nodes undergo significant structural alterations in immunocompetent mice, and this may represent a primer for papillary thyroid carcinoma (PTC) metastasis.

摘要

背景

本研究的目的是在甲状腺特异性表达致癌性Braf且有或无Pten功能不全的基因工程小鼠中,定义并表征甲状腺肿瘤引流淋巴结。

方法

在肿瘤内注射亚甲蓝后,实时观察甲状腺的淋巴引流情况。将甲状腺/肿瘤与呼吸系统整块切除,进行组织学分析。

结果

尽管携带Braf突变的小鼠体型比其野生型(WT)同窝小鼠小,但其甲状腺和颈深淋巴结的尺寸明显更大。此外,肿瘤引流淋巴结的淋巴窦增多且增大,分布于整个皮质和髓质。在所有携带Braf突变的小鼠中均观察到肿瘤反应性淋巴结病和组织细胞增多症,但无明显转移。

结论

在免疫功能正常的小鼠中,肿瘤引流淋巴结会发生显著的结构改变,这可能是甲状腺乳头状癌(PTC)转移的前奏。